Equities

Unibios Holdings SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Unibios Holdings SA

Actions
  • Price (EUR)2.72
  • Today's Change0.06 / 2.26%
  • Shares traded12.40k
  • 1 Year change+77.78%
  • Beta1.1922
Data delayed at least 20 minutes, as of Feb 16 2026 15:09 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Unibios Holdings SA, formerly known as Biossol S.A., is a Greece-based company engaged in promoting technologies for the responsible use of water and energy. The Company develops, installs and maintains desalination and filtering solutions for municipalities, and the manufacturing, power generation and hospitality industries. The Company’s main operating division, Watera International, which installs and operates water processing systems in Europe, the Middle East and Africa, and is present through subsidiaries in five European Countries. The Company’s subsidiaries include Biossol SA, active in the field of Heating Ventilation and Air Conditioning (HVAC); Culligan Hellas, engaged in the field of water treatment technologies in Greece; Aquatronics, which is active in the market for private swimming pools, domestic filtering systems and Spas; Biossol Construction Tools, which operates in the area of Access Scaffolding service, and Ifestos.

  • Revenue in EUR (TTM)15.31m
  • Net income in EUR2.39m
  • Incorporated1940
  • Employees83.00
  • Location
    Unibios Holdings SA1i & 18i Odos, VIO.PA, Ano LiosiaATHINA 133 41GreeceGRC
  • Phone+30 2 106037030
  • Fax+30 2 103421001
  • Websitehttps://www.unibios.gr/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BIOSK:ATH since
announced
Transaction
value
Osmosun SAAnnounced23 May 202523 May 2025Announced58.14%1.81m
Data delayed at least 20 minutes, as of Feb 16 2026 15:09 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Qleanair AB42.95m2.63m37.89m116.0014.421.876.830.88221.871.8730.2814.450.76163.5915.113,920,509.004.674.5510.878.4668.6468.206.136.150.43936.610.450321.920.9776-1.602,046.27-16.08-6.26--
Christie Group plc68.83m3.14m40.42m633.0012.676.897.740.58730.10460.13772.300.19242.00--6.0594,543.459.100.263919.710.4939----4.560.16431.124.830.6335402.1315.37-5.00147.64-22.238.3012.47
Circle SpA14.69m1.47m42.94m106.0029.462.8812.132.920.30480.30482.993.110.560251.021.62138,545.605.626.539.4211.2667.6761.5410.0210.701.97--0.1156--3.3120.090.290529.78-21.37--
Deufol SE309.39m3.32m44.01m2.37k13.040.34961.660.14220.3910.39136.4214.591.136.918.09133,243.301.331.601.812.1364.1661.721.181.610.89932.170.404242.045.154.59-40.295.77-2.08--
Gattaca PLC458.76m2.14m44.97m381.0020.901.3311.960.0980.05930.070212.650.93134.91--7.311,046,982.002.290.55896.181.409.7310.420.4660.1262----0.046137.662.40-5.69142.0620.66-55.16--
Unibios Holdings SA15.31m2.39m45.73m83.0019.152.4215.772.990.13890.13890.88931.100.54952.002.42193,749.408.583.1811.804.4139.9637.9615.627.211.69--0.2693--13.4212.03-49.4059.1823.11--
Careium AB (publ)80.65m3.07m45.94m562.0014.970.71394.620.56961.341.3435.1128.020.796110.883.941,519,751.003.342.704.023.2243.9341.514.193.471.463.320.2353---1.9110.26-44.3511.5717.51--
TGS Dis Ticaret AS4.31m1.83m47.63m15.0026.179.0121.9411.066.296.2914.7218.270.01150.000.012513,128,490.000.4880.453333.1823.7772.68--42.5827.211.00--0.0094--23.7752.99162.0050.5494.93--
Generic Sweden AB (publ)17.21m3.04m48.52m22.0015.898.7615.402.822.632.6314.884.772.11247.989.058,285,364.0037.3731.9254.8148.5039.0543.9217.6715.572.93--0.0075.6223.7520.5616.9025.3620.7314.87
BRAIN Biotech AG50.22m-11.74m49.38m281.00--26.82--0.9833-0.5375-0.53752.300.08430.64762.336.18178,704.60-15.26-10.94-21.28-14.9457.4356.34-23.56-16.730.9104-4.670.7187---9.525.15-5.53---10.89--
White Pearl Technology Group AB-9.44bn-9.44bn49.57m0.00--2.67----------6.66----------20.34--25.14------12.533.11--0.1993--29.2537.98-20.01------
Hercules PLC123.90m2.92m49.58m758.0013.673.2013.160.40020.0392-0.03431.580.1672.621,861.225.45142,129.306.163.2614.096.4813.6217.362.351.671.214.410.518142.6627.7827.13-1.98-2.4812.60--
Synectics PLC74.78m5.03m50.14m292.009.920.99747.250.67050.24710.24713.672.461.065.993.54222,678.107.130.30119.840.423242.0039.646.730.38521.631,120.800.0371180.6513.60-4.0246.9714.295.1728.19
Arribatec Group ASA50.50m-4.75m51.65m242.00--1.5352.351.02-7.20-6.2520.035.511.1935.644.621,813,010.00-11.23-13.32-18.45-19.3774.4477.27-9.41-13.221.12-44.040.092--0.3058131.41-258.80--20.48--
Itera ASA74.76m2.27m53.36m705.0023.7011.8410.430.71390.30890.308910.080.61853.20--6.811,160,835.009.6921.0225.4364.8892.5392.013.037.10--8.020.526153.29-2.628.66-38.29-3.41-11.12-12.94
Data as of Feb 16 2026. Currency figures normalised to Unibios Holdings SA's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.